Benzinga · Sep 16, 2026
This Nu Holdings Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Analysts downgraded NU, BAK, CLLS and CBZ; price targets for NU, BAK and CLLS were cut sharply.
CC
NYSE · CCAP
Crescent Capital BDC, Inc.
Financial Services · Asset Management
$9.88
Up+$0.04 (+0.41%)
Updated Sep 17, 2026, 3:14 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 551.84M
- P/E ratio
- 12.49
- Dividend yield
- 22.77%
- 52-week range
- $9.76 – $14.08
- Volume
- 334.94K
- Avg. volume
- 204.12K
Price performance
CCAP price history
1M range · 20 trading sessions · Daily adjusted prices
CCAP closed at $9.88 after 20 trading sessions, down 8.60% for the selected period.
- Last close
- $9.88
- Period change
- -8.60%
- Period low
- $9.84
- Period high
- $10.81
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $9.82 | $9.95 | $9.78 | $9.88 | 334.94K |
| Sep 15, 2026 | $9.95 | $9.95 | $9.76 | $9.84 | 289.19K |
| Sep 14, 2026 | $9.96 | $10.06 | $9.89 | $9.94 | 198.19K |
| Sep 11, 2026 | $9.94 | $10.03 | $9.885 | $9.92 | 259.12K |
| Sep 10, 2026 | $9.935 | $10.08 | $9.88 | $9.93 | 532.28K |
| Sep 9, 2026 | $10.25 | $10.35 | $10.16 | $10.23 | 510.13K |
| Sep 8, 2026 | $10.34 | $10.43 | $10.285 | $10.29 | 496.04K |
| Sep 4, 2026 | $10.34 | $10.505 | $10.3281 | $10.37 | 131.49K |
| Sep 3, 2026 | $10.42 | $10.64 | $10.26 | $10.45 | 211.25K |
| Sep 2, 2026 | $10.47 | $10.58 | $10.38 | $10.40 | 301.08K |
| Sep 1, 2026 | $10.60 | $10.64 | $10.47 | $10.48 | 284.47K |
| Aug 31, 2026 | $10.42 | $10.705 | $10.42 | $10.62 | 274.13K |
| Aug 28, 2026 | $10.65 | $10.7399 | $10.53 | $10.54 | 151.43K |
| Aug 27, 2026 | $10.58 | $10.695 | $10.50 | $10.60 | 216.31K |
| Aug 26, 2026 | $10.71 | $10.74 | $10.50 | $10.57 | 281.56K |
| Aug 25, 2026 | $10.77 | $10.8249 | $10.691 | $10.695 | 245.87K |
| Aug 24, 2026 | $10.74 | $10.79 | $10.58 | $10.75 | 226.99K |
| Aug 21, 2026 | $10.70 | $10.76 | $10.59 | $10.71 | 224.13K |
| Aug 20, 2026 | $10.76 | $10.865 | $10.65 | $10.68 | 201.61K |
| Aug 19, 2026 | $10.82 | $11.04 | $10.77 | $10.81 | 172.96K |
Latest CCAP news
The latest Smart Investors Daily articles mentioning CCAP.
Stock researchCompany · Overview
CCAP research
Overview
Company profile and research snapshot.
Company profile
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $17.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | B of A Securities | Neutral | — |
| Aug 17, 2026 | Keefe, Bruyette & Woods | Market Perform | — |
| Aug 12, 2026 | B. Riley Securities | Neutral | — |
| Aug 12, 2026 | Ladenburg Thalmann | Buy | — |
| Aug 12, 2026 | Wells Fargo | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 15, 2026
This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Banco Santander Brasil, Ribbon Communications, Cellectis, Scholar Rock, with mixed price-target changes.
Benzinga · Sep 10, 2026
This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.
Benzinga · Sep 10, 2026
B of A Securities Downgrades Crescent Capital BDC to Neutral, Lowers Price Target to $10.25
B of A Securities analyst Derek Hewett downgrades Crescent Capital BDC (NASDAQ:CCAP) from Buy to Neutral and lowers the price target from $13 to $10.25.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
